Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,295 papers from all fields of science
Search
Sign In
Create Free Account
Stage IIA1 Cervical Cancer
Known as:
FIGO Stage IIA1 Cervical Carcinoma
Stage IIA1 includes: T2a1, N0, M0. Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion. T2a1…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
18 relations
Cervix Epithelium
Cervix Uteri
ERBB2 Gene Amplification
Epithelial Cells
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abnormal menstruation after radical trachelectomy and its effects on fertility
Mari Matsuoka
,
Atsuko Taga
,
+7 authors
T. Nagano
The journal of obstetrics and gynaecology…
2019
Corpus ID: 195067778
To evaluate and identify the risk factors for abnormal menstruation after radical trachelectomy.
2019
2019
The Proportion of Lymph Node Metastasis in Patients with Stage IIA1 and IIA2 Cervical Cancer who were Treated for Radical Hysterectomy and Pelvic Lymphadenectomy
A. Andrijono
,
Wahyu Ginealdy
Indonesian Journal of Obstetrics and Gynecology
2019
Corpus ID: 86568277
Objective: This study was designed to determine a difference in prognosis of stage IIA1 cervical cancer compared to stage IIA2…
Expand
2018
2018
Oncologic outcome of stage IIA1 cervical cancer: Is surgical treatment justified?
Y. Yagur
,
O. Weitzner
,
R. Eitan
,
A. Fishman
,
L. Helpman
Gynecologic Oncology
2018
Corpus ID: 81595799
2017
2017
Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: Analysis of the National Cancer Data Base.
W. Haque
,
V. Verma
,
M. Fakhreddine
,
S. Hatch
,
E. Butler
,
Bin S. Teh
Gynecologic Oncology
2017
Corpus ID: 33996871
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE